Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP219900.RA5mds4iPuGrUxbkE4Ffy4eYZZ23_6GbcxqMVNVV45nrU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP219900.RA5mds4iPuGrUxbkE4Ffy4eYZZ23_6GbcxqMVNVV45nrU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP219900.RA5mds4iPuGrUxbkE4Ffy4eYZZ23_6GbcxqMVNVV45nrU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP219900.RA5mds4iPuGrUxbkE4Ffy4eYZZ23_6GbcxqMVNVV45nrU130_provenance.
- NP219900.RA5mds4iPuGrUxbkE4Ffy4eYZZ23_6GbcxqMVNVV45nrU130_assertion description "[Of the 80 specimens of primary prostate cancer examined by receptor binding assays, 50 ( approximately 63%) showed high-affinity, low-capacity binding sites for bombesin/GRP, and 12 of these 50 receptor-positive specimens also showed a second binding site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219900.RA5mds4iPuGrUxbkE4Ffy4eYZZ23_6GbcxqMVNVV45nrU130_provenance.
- NP219900.RA5mds4iPuGrUxbkE4Ffy4eYZZ23_6GbcxqMVNVV45nrU130_assertion evidence source_evidence_literature NP219900.RA5mds4iPuGrUxbkE4Ffy4eYZZ23_6GbcxqMVNVV45nrU130_provenance.
- NP219900.RA5mds4iPuGrUxbkE4Ffy4eYZZ23_6GbcxqMVNVV45nrU130_assertion SIO_000772 10679759 NP219900.RA5mds4iPuGrUxbkE4Ffy4eYZZ23_6GbcxqMVNVV45nrU130_provenance.
- NP219900.RA5mds4iPuGrUxbkE4Ffy4eYZZ23_6GbcxqMVNVV45nrU130_assertion wasDerivedFrom befree-20140225 NP219900.RA5mds4iPuGrUxbkE4Ffy4eYZZ23_6GbcxqMVNVV45nrU130_provenance.
- NP219900.RA5mds4iPuGrUxbkE4Ffy4eYZZ23_6GbcxqMVNVV45nrU130_assertion wasGeneratedBy ECO_0000203 NP219900.RA5mds4iPuGrUxbkE4Ffy4eYZZ23_6GbcxqMVNVV45nrU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP219900.RA5mds4iPuGrUxbkE4Ffy4eYZZ23_6GbcxqMVNVV45nrU130_provenance.